IOVAIovance Biotherapeutics, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9M

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-0.48

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$47M

Total Liabilities

$2M

Stockholders' Equity

$45M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9M	-$5M	-100.6%
Operating Income	-$12M	-$23M	+46.8%
Net Income	-$12M	-$25M	+52.6%

IOVA FY 2014 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena